Señales en vivo de 600421.SS | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 may 2024 @ 03:00):

Hubei Huarong Holding Co.,Ltd. produces and distributes pharmaceutical products in China. The company's principal pharmaceutical products include Gucining Capsules and Huoxue Tongmai Capsules...

Stats
Volumen de hoy	5.40M
Volumen promedio	5.74M
Capitalización de mercado	1.28B
EPS	CNY-0.00425 ( 2023-06-30 )
Próxima fecha de ganancias	( CNY0 ) 2024-05-23
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	-217.33
ATR14	CNY0.0130 (0.20%)

Volumen Correlación

Largo: 0.02 (neutral)

Corto: 0.20 (neutral)

Signal:(51.402) Neutral

Hubei Huarong Holding Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hubei Huarong Holding Correlación - Moneda/Commodity

-0.18
( neutral )

-0.20
( neutral )

0.00
( neutral )

-0.79
( moderate negative )

0.36
( neutral )

0.17
( neutral )

Hubei Huarong Holding Finanzas

Annual	2023
Ingresos:	CNY122.12M
Beneficio Bruto:	CNY19.92M (16.31 %)
EPS:	CNY-0.0400

FY	2023
Ingresos:	CNY122.12M
Beneficio Bruto:	CNY19.92M (16.31 %)
EPS:	CNY-0.0400

FY	2022
Ingresos:	CNY125.19M
Beneficio Bruto:	CNY12.62M (10.08 %)
EPS:	CNY-0.0314

FY	2021
Ingresos:	CNY130.35M
Beneficio Bruto:	CNY14.90M (11.43 %)
EPS:	CNY-0.0446

Financial Reports:

No articles found.

Hubei Huarong Holding

Hubei Huarong Holding Co.,Ltd. produces and distributes pharmaceutical products in China. The company's principal pharmaceutical products include Gucining Capsules and Huoxue Tongmai Capsules. It also develops biological products, pharmaceuticals, environment-protection, and agricultural products, as well as related technologies. The company was formerly known as Hubei Yangfan Holding Co., Ltd. and changed its name to Hubei Huarong Holding Co.,Ltd. in November 2020. Hubei Huarong Holding Co.,Ltd. was founded in 1997 and is headquartered in Wuhan, China.